The US GLP-1 user population is large and growing, and current government policy and drug-provider pricing strategies are breaking down adoption barriers and may make it grow faster, said Rick Miller, partner and marketing effectiveness practice lead at Big Chalk
TorHoerman Law is reviewing claims involving NAION, sudden vision loss, and other serious eye injuries allegedly associated with Ozempic, Wegovy, Rybelsus, and other semaglutide medications
The Phase 2 trial enrolled participants with obesity and evaluated multiple dose levels over 48 weeks: 1 mg dose: 8.7% average body weight reduction 4 mg dose (escalated from 2 mg): 17.1% average body weight reduction 8 mg dose (escalated from 2 mg): 22.8% average body weight reduction 12 mg dose (escalated from 2 mg): 24.2% average body weight reduction Placebo: 2.1% average body weight reduction Those Phase 2 numbers were striking enough
Patients should be advised to avoid high fat-rich meals and reduce the portion size of their meals
It is suitable for women with sensitive skin and is well tolerated
